CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Techniques Science-Santé (T2S)

14 décembre 2021

CDG Invest Growth announces the completion of its exit from Techniques Science-Santé (T2S) through a sale to a holding company owned by Helios investment fund.

CDG Invest Growth acquired a significant minority stake in T2S  in June 2016 through the Capmezzanine II fund.

Founded in 1992 by Mr. Abderraouf Sordo and his four partners, T2S has become, in less than three decades, the undisputed leader in the distribution and maintenance of medical equipment in Morocco and then in French-speaking Africa, with revenues of around 700 Mdhs in 2020. T2S’s success is the result of long-standing relationships with leading medical device manufacturers, as well as the trust and legitimacy it enjoys with its customers.

Click here for more information about T2S

Decembre 17, 2025 — CDG Invest Growth announces the exit of Capmezzanine III Fund from Soludia Maghreb, a key player in the manufacturing of hemodialysis products in Morocco. This transaction consists in Sothema’s strategic acquisition of 99.99% of Soludia Maghreb’s share capital and voting rights. Founded in 1998, Soludia Maghreb is a pharmaceutical company specializing […]

CDG Invest Growth acquires a significant minority stake in Comaner, a leading operator in the agrifood industry in Morocco. Comaner is specialized in the importation and distribution of food ingredients and additives. The company has become a one-stop-shop in the food industry offering its customers a large catalog of products. Through its subsidiary, Vialys, the Group also […]

CDG Invest Growth announces the signing of an agreement aiming at acquiring a minority stake in Sodalmu, a Moroccan company specialized in the production and distribution of sodas under the brand “ICE”, through Capmezzanine V, FPCC-RFA, the fifth fund managed by CDG Invest Growth.The completion of the transaction remains subject to the Moroccan Antitrust Authority […]